Dr. Macdonald is a Hematologist at the Ottawa Hospital and Assistant Professor in the Department of Medicine at the University of Ottawa. He received his MD at Queen’s University and did residencies in Internal Medicine and Hematology at Dalhousie University. He then did a Clinical Trials Fellowship at the National Cancer Institute of Canada Clinical Trials Group, then a clinical lymphoma fellowship at the BC Cancer Agency in Vancouver. He was Chair of the Hematology Cancer Site Team for Cancer Care Nova Scotia for ten years before moving to Ottawa in 2017. He is a member of the Scientific Advisory Board for Lymphoma Canada. His clinical and research interests are in clinical trials of novel therapies in lymphoma and CLL.

Manager of Patient Programs, Research and Advocacy

Dr. Gwynivere Davies is an assistant professor at McMaster University and malignant hematologist at the Juravinski Cancer Centre in Hamilton specializing in lymphoma, autologous stem cell transplant and CAR-T. She is the Division Head for Malignant Hematology, and her research interests include population and health outcomes for patients with lymphoma.

Manager of Patient Programs, Research and Advocacy

Dr. Pamela Skrabek is hematologist with CancerCare Manitoba, and an assistant professor of internal medicine at the Max Rady College of Medicine. Dr. Skrabek’s research contributions have focused on non-Hodgkin lymphomas with a combination of epidemiological and translational research projects. As lead of the Lymphoproliferative Disease Site Group (DSG), part of her role is to oversee clinical research activities and collaborate in clinical trials provincially and nationally. She is also a member of Lymphoma Canada’s Scientific Advisory Board and is the new chair of LC’s Patient and Support Research Committee.

Manager of Patient Programs, Research and Advocacy

Dr. Robert Puckrin is a hematologist and staff physician in the Alberta Blood and Marrow Transplant Program at the University of Calgary with interests in lymphoma, CAR-T cell therapy, stem cell transplantation, and clinical research.

Manager of Patient Programs, Research and Advocacy

Manager of Patient Programs, Research and Advocacy

Dr. Macdonald is a Hematologist at the Ottawa Hospital and Assistant Professor in the Department of Medicine at the University of Ottawa. He received his MD at Queen’s University and did residencies in Internal Medicine and Hematology at Dalhousie University. He then did a Clinical Trials Fellowship at the National Cancer Institute of Canada Clinical Trials Group, then a clinical lymphoma fellowship at the BC Cancer Agency in Vancouver. He was Chair of the Hematology Cancer Site Team for Cancer Care Nova Scotia for ten years before moving to Ottawa in 2017. He is a member of the Scientific Advisory Board for Lymphoma Canada. His clinical and research interests are in clinical trials of novel therapies in lymphoma and CLL.

Manager of Patient Programs, Research and Advocacy

Dr. Shannon Murphy is a Hematologist and Assistant Professor at Dalhousie University and practices at the QEII Health Sciences Centre in Halifax, NS. Prior to joining the Division of Hematology and Hematologic Oncology in Halifax, Dr. Murphy completed her internal medicine and hematology training at Dalhousie University, followed by a 1-year clinical lymphoma fellowship with BC Cancer in Vancouver. Her practice focuses on lymphoma and chronic lymphocytic leukemia.

Dr. Carolyn Owen is an Associate Professor in the Division of Hematology & Hematological Malignancies at the University of Calgary. She completed internal medicine training in Ottawa, Hematology training in Vancouver followed by a research fellowship in molecular genetics at Barts and the London School of Medicine in London, UK.  Her prior research is focussed on familial myelodysplasia and acute myeloid leukemia. Her current clinical interests are low grade lymphoma and chronic lymphocytic leukemia and she is the local principal investigator at the Tom Baker Cancer Centre for several clinical trials in these areas.  

Dr. Nathalie Johnson is an associate professor in the departments of Medicine and Oncology and Director of the division of Hematology at McGill University. She is a hematologist at the Jewish General Hospital in Montreal who performs translational and clinical research since 2010.  Her research focuses on studying mechanisms of therapeutic resistance to conventional and novel therapies and identifying early relapsed lymphoma using plasma circulating tumor DNA.  She is the primary investigator of several clinical trials that test novel treatments for patients with newly diagnosed or relapsed lymphoma. She is also the program director for Clinical Investigator Program at McGill University and President of the Canadian Society for Clinical Investigation (CSCI).

Dr. Keating is a hematologist at the QEII Health Science Center and associate professor of medicine at Dalhousie University in Halifax, Nova Scotia. She has a clinical and research focus in lymphoma where she selects the many clinical trials made available to lymphoma patients at her center. She additionally has an academic focus in medical education. She has a master’s in medical education from Acadia University and is the program director of the Hematology Residency Training Program and is the unit head of the Faculty of Medicine's Skilled Clinician Unit at Dalhousie.

Dr. Anthea Peters is a hematologist based at the Cross Cancer Institute in Edmonton, Alberta and an Associate Professor in the Department of Oncology at the University of Alberta. She completed her MD at the University of Saskatchewan, internal medicine residency training at the University of Alberta and hematology training as well as a lymphoma fellowship at the University of Calgary. Her clinical and research interests are centered around lymphoma and chronic lymphocytic leukemia (CLL), with a special interest in post-transplant lymphoproliferative disorders. 

Dr. Joanne Hickey is a Hematologist with Newfoundland and Labrador Health Services and she is an associate professor within the Discipline of Medicine at Memorial University.  Her academic interests focus on medical education - working with both undergraduate and postgraduate programs, implementing curriculum innovations to improve the education of new physicians.  As the former Medical Director of the Newfoundland and Labrador Cellular Therapy and Transplant Program, she has a particular interest in the treatment of Hodgkin Lymphoma.

Dr Minakshi Taparia completed her training in internal medicine in India and hematology training in Australia and united kingdom . She has been working as a clinical professor at the university of Alberta Hospital since 2006. She has a special interest in rare diseases including Cutaneous Lymphomas, Histiocytic disorders, mast cell disorders, castlemans disease , allogenic transplant and a chunk of her time is dedicated to taking care of patients with these diseases. She has been involved in a number of clinical trials and is an  advocate to get treatment available to treat these diseases in our province.

Dr. Shannon Murphy is a Hematologist and Assistant Professor at Dalhousie University and practices at the QEII Health Sciences Centre in Halifax, NS. Prior to joining the Division of Hematology and Hematologic Oncology in Halifax, Dr. Murphy completed her internal medicine and hematology training at Dalhousie University, followed by a 1-year clinical lymphoma fellowship with BC Cancer in Vancouver. Her practice focuses on lymphoma and chronic lymphocytic leukemia.

Dr. Nathalie Johnson is an associate professor in the departments of Medicine and Oncology and Director of the division of Hematology at McGill University. She is a hematologist at the Jewish General Hospital in Montreal who performs translational and clinical research since 2010.  Her research focuses on studying mechanisms of therapeutic resistance to conventional and novel therapies and identifying early relapsed lymphoma using plasma circulating tumor DNA.  She is the primary investigator of several clinical trials that test novel treatments for patients with newly diagnosed or relapsed lymphoma. She is also the program director for Clinical Investigator Program at McGill University and President of the Canadian Society for Clinical Investigation (CSCI).

Dr. Keating is a hematologist at the QEII Health Science Center and associate professor of medicine at Dalhousie University in Halifax, Nova Scotia. She has a clinical and research focus in lymphoma where she selects the many clinical trials made available to lymphoma patients at her center. She additionally has an academic focus in medical education. She has a master’s in medical education from Acadia University and is the program director of the Hematology Residency Training Program and is the unit head of the Faculty of Medicine's Skilled Clinician Unit at Dalhousie.

Dr. Anthea Peters is a hematologist based at the Cross Cancer Institute in Edmonton, Alberta and an Associate Professor in the Department of Oncology at the University of Alberta. She completed her MD at the University of Saskatchewan, internal medicine residency training at the University of Alberta and hematology training as well as a lymphoma fellowship at the University of Calgary. Her clinical and research interests are centered around lymphoma and chronic lymphocytic leukemia (CLL), with a special interest in post-transplant lymphoproliferative disorders. 

Dr. Carolyn Owen is an Associate Professor in the Division of Hematology & Hematological Malignancies at the University of Calgary. She completed internal medicine training in Ottawa, Hematology training in Vancouver followed by a research fellowship in molecular genetics at Barts and the London School of Medicine in London, UK.  Her prior research is focussed on familial myelodysplasia and acute myeloid leukemia. Her current clinical interests are low grade lymphoma and chronic lymphocytic leukemia and she is the local principal investigator at the Tom Baker Cancer Centre for several clinical trials in these areas.  

Dr. Macdonald is a Hematologist at the Ottawa Hospital and Assistant Professor in the Department of Medicine at the University of Ottawa. He received his MD at Queen’s University and did residencies in Internal Medicine and Hematology at Dalhousie University. He then did a Clinical Trials Fellowship at the National Cancer Institute of Canada Clinical Trials Group, then a clinical lymphoma fellowship at the BC Cancer Agency in Vancouver. He was Chair of the Hematology Cancer Site Team for Cancer Care Nova Scotia for ten years before moving to Ottawa in 2017. He is a member of the Scientific Advisory Board for Lymphoma Canada. His clinical and research interests are in clinical trials of novel therapies in lymphoma and CLL.

Dr. Joanne Hickey is a Hematologist with Newfoundland and Labrador Health Services and she is an associate professor within the Discipline of Medicine at Memorial University.  Her academic interests focus on medical education - working with both undergraduate and postgraduate programs, implementing curriculum innovations to improve the education of new physicians.  As the former Medical Director of the Newfoundland and Labrador Cellular Therapy and Transplant Program, she has a particular interest in the treatment of Hodgkin Lymphoma.

Dr Minakshi Taparia completed her training in internal medicine in India and hematology training in Australia and united kingdom . She has been working as a clinical professor at the university of Alberta Hospital since 2006. She has a special interest in rare diseases including Cutaneous Lymphomas, Histiocytic disorders, mast cell disorders, castlemans disease , allogenic transplant and a chunk of her time is dedicated to taking care of patients with these diseases. She has been involved in a number of clinical trials and is an  advocate to get treatment available to treat these diseases in our province.

Charlene is a Nurse Practitioner in the Division of Hematology at the Health Science Centre and the Dr. H Bliss Murphy Cancer Centre in St. John’s. She has been a Registered Nurse for 27 years and a Nurse Practitioner for 18 years. She is a true “Hem/Onc” nurse at heart - having started her nursing career as an inpatient Hematology/Oncology nurse and never left the area. Throughout her NP career she has worked in both inpatient and outpatient settings, with the NL Cell Therapy and Transplant Program and is currently the Outpatient Nurse Practitioner in Hematology Oncology. In her current practice, Charlene works with patients undergoing systemic chemotherapy with any Hematological malignancy.

Manager of Patient Programs, Research and Advocacy

Manager of Patient Programs, Research and Advocacy

Sabina Vohra-Miller has an MSc in clinical pharmacology and toxicology and is currently a Doctor of Public Health candidate at the Dalla Lana School of Public Health. She is the founder of Unambiguous Science, an educational platform that aims to make science approachable. She is also the co-founder of the Vohra Miller Foundation, a philanthropic endeavor to make systemic, sustainable, and meaningful changes to healthcare in Canada.Sabina has been involved with Lymphoma Canada for nearly a decade, first as a volunteer and then as a board member for 6 years. She recently finished her term and stepped down from the role of vice chair of the board.

Sarah Nadeau is a nurse practitioner working in complex hematology at the Saskatoon Cancer Center. She received her Masters of Nursing (Nurse Practitioner) from the University of Saskatchewan in 2022. Her areas of practice include CAR-T, non-Hodgkins lymphoma, CLL, and allogeneic stem cell transplant long term follow up.

Renee Wishart has been with BC Cancer- Vancouver Center Since 2017 in the role of Counsellor.  Specifically, Renee works with patients who have been diagnosed with blood cancers or lung cancer.  Through this role she has been able to provide one-to-one counselling, family counselling, and has facilitated both supportive and psychoeducational groups for patients. Renee works with multi disciplined teams to  provide both outpatient and inpatient support.

Jean LaMantia is a Hodgkin lymphoma cancer survivor and registered dietitian. She uses her personal experience and training in clinical nutrition to help others at every stage of their cancer experience. She has written three books, writes a popular blog and hosts webinars and classes for people with cancer, lymphedema and lipedema.  

Manager of Patient Programs, Research and Advocacy

Dr. Macdonald is a Hematologist at the Ottawa Hospital and Assistant Professor in the Department of Medicine at the University of Ottawa. He received his MD at Queen’s University and did residencies in Internal Medicine and Hematology at Dalhousie University. He then did a Clinical Trials Fellowship at the National Cancer Institute of Canada Clinical Trials Group, then a clinical lymphoma fellowship at the BC Cancer Agency in Vancouver. He was Chair of the Hematology Cancer Site Team for Cancer Care Nova Scotia for ten years before moving to Ottawa in 2017. He is a member of the Scientific Advisory Board for Lymphoma Canada. His clinical and research interests are in clinical trials of novel therapies in lymphoma and CLL.

Alison Cumming (MATS) is a Certified Spiritual Health Practitioner at BC Cancer.   Alison has her Master’s in Theology and has post-graduate training in Clinical Psychospiritual Education by the Canadian Association for Spiritual Care, End-of-Life Doula training from Douglas College and is a licensed Minister.  She has a deep love of the arts, engaging creativity in all that she does; she is an intercessor, a vocalist and a playwright and enjoys working with pottery, watercolour and pastels as part of her self-care time.

Manager of Patient Programs, Research and Advocacy

Katherine-Ann Piedalue is a Doctor of Psychology student at Memorial University in Newfoundland, working under the supervision of Dr. Sheila Garland. She earned her Bachelor of Arts in Psychology with a minor in Religious Studies from the University of Calgary. Following her undergraduate studies, Katherine-Ann continued her research in Psychosocial Oncology at the Tom Baker Cancer Centre, co-authoring several published papers on integrative oncology approaches.

Manager of Patient Programs, Research and Advocacy

Dr. Culos-Reed is a Professor of Health and Exercise Psychology in the Faculty of Kinesiology; Adjunct Professor in the Department of Oncology in the Cumming School of Medicine; and Director of the Health and Wellness Lab and Thrive Centre. She holds a Research Associate appointment with the Department of Psychosocial Resources at the Tom Baker Cancer Centre, Cancer Care, Alberta Health Services, and is a Killam Laureate. 

Dr. Culos-Reed’s research takes a transdisciplinary approach to understanding and improving the quality of life of individuals living with and beyond cancer, developing, delivering, and evaluating physical activity programs to address the physical and psychological challenges experienced throughout treatment and into survivorship. This research includes national and international collaborations, working with populations from pediatric to adult, including those with advanced cancer, and most recently includes a Canadian Institute of Health Research-Canadian Cancer Society (CIHR-CCS) Cancer Survivorship Team Grant (2020-26), with additional support from Alberta Cancer Foundation (ACF), to bring her team’s exercise oncology program to underserved rural and remote populations across Canada. 

Manager of Patient Programs, Research and Advocacy

Manager of Patient Programs, Research and Advocacy